Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,462.00    5.60 (0.38%)
Bid:
1,462.00
Ask:
1,462.20
Spread: 0.20 (0.014%)
Market Cap: £250.71b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

HSBC tender offers - indicative results

23 Sep 2024 10:00

RNS Number : 2343F
HSBC Holdings PLC
23 September 2024
 

 

 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES OF AMERICA AND THE DISTRICT OF COLUMBIA) (THE 'UNITED STATES') OR IN OR INTO ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS DOCUMENT.

23 September 2024

 

HSBC HOLDINGS PLC

ANNOUNCES INDICATIVE RESULTS OF TENDER OFFERS TO PURCHASE NOTES FOR CASH

 

HSBC Holdings plc (the 'Issuer') announces today the indicative results of its invitations to holders of: (a) the EUR1,000,000,000 0.309% Fixed to Floating Rate Notes due 2026 (ISIN: XS2251736646) (of which EUR1,000,000,000 is currently outstanding) (the 'November 2026 Notes') and/or; (b) the EUR1,250,000,000 2.50% Notes due March 2027 (ISIN: XS1379184473) (of which EUR1,250,000,000 is currently outstanding) (the 'March 2027 Notes') (each a 'Series' and together, the 'Notes'), to tender such Notes for purchase by the Issuer for cash subject to satisfaction or waiver of the New Financing Condition (each such invitation an 'Offer' and, together, the 'Offers').

Capitalised terms used and not otherwise defined in this announcement have the meanings given in the tender offer memorandum prepared by the Issuer dated 16 September 2024 (the 'Tender Offer Memorandum'). This announcement must be read in conjunction with the Tender Offer Memorandum.

INDICATIVE RESULTS OF THE OFFERS

On 17 September 2024, the Issuer announced that the indicative Maximum Acceptance Amount for the Offers had been set at approximately EUR2,250,000,000.

The Expiration Deadline for the Offers was 4.00pm (London time) on 20 September 2024. As at the Expiration Deadline, EUR495,386,000 in aggregate principal amount of the November 2026 Notes and EUR490,415,000 in aggregate principal amount of the March 2027 Notes have been validly tendered pursuant to the Offers.

The Issuer announces, on a non-binding and indicative basis only, that, conditional upon the satisfaction or waiver of the New Financing Condition, it expects to accept valid tenders of Notes pursuant to the Offers, with an indicative Series Acceptance Amount for the November 2026 Notes equal to EUR495,386,000 and an indicative Series Acceptance Amount for the March 2027 Notes equal to EUR490,415,000. All valid tenders of Notes pursuant to the Offers are indicatively expected to be accepted and no pro-ration factor is expected to be applicable.

The Issuer reserves the right, in its sole and absolute discretion, at any time to amend or waive any of the terms and conditions of the Offers (including the New Financing Condition) as set out in the Tender Offer Memorandum. Subject to the satisfaction or waiver of the New Financing Condition on or prior to 25 September 2024, the settlement of the Offers is expected to take place on 25 September 2024.

The Pricing Time is expected to be at or around 11.00am (London time) today. The Issuer expects to announce the final results of the Offers as soon as reasonably practicable thereafter.

 

The Dealer Manager

HSBC Bank plc 8 Canada SquareLondon E14 5HQ

United Kingdom

Telephone: +44 (0) 20 7992 6237

Attention: Liability Management, DCM

Email: LM_EMEA@hsbc.com

The Tender Agent

Kroll Issuer Services Limited

The Shard32 London Bridge StreetLondon SE1 9SG

Telephone: +44 (0) 20 7704 0880

Attention: Owen Morris

Email: hsbc@is.kroll.com

Tender Offer Website: https://deals.is.kroll.com/hsbc

 

 

DISCLAIMER

The offer period for the Offers has now expired. No further tenders of any Notes may be made pursuant to the Offers. This announcement must be read in conjunction with the Tender Offer Memorandum. No offer to acquire or exchange any securities is being made pursuant to this announcement. This announcement and the Tender Offer Memorandum contain important information, which must be read carefully. If any Noteholder is in any doubt as to the action it should take, it is recommended to seek its own financial, legal and any other advice, including in respect of any tax financial, accounting, regulatory and tax consequences, immediately from its broker, bank manager, solicitor, accountant or other independent financial, tax or legal adviser. None of the Issuer, the Dealer Manager or the Tender Agent or their respective directors, employees or affiliates will have any liability or responsibility in respect of any decision of a Noteholder as to their decision of whether to participate or not to participate in the Offers.

Investor enquiries to:Greg Case +44 (0) 20 7992 3825 investorrelations@hsbc.com

 

Media enquiries to:

Press Office +44 (0) 20 7991 8096 pressoffice@hsbc.com

 

Note to editors:

 

HSBC Holdings plc

HSBC Holdings plc, the parent company of the HSBC Group, is headquartered in London. HSBC serves customers worldwide from offices in 60 countries and territories. With assets of US$2,975bn at 30 June 2024, HSBC is one of the world's largest banking and financial services organisations.

 

ends/all

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TENGIGDCGSDDGSX
Date   Source Headline
10th Jul 20269:30 amRNSOverseas Regulatory Announcement - Grant of Awards
2nd Jul 20263:45 pmRNSNotice of redemption
30th Jun 20264:00 pmRNSNotification of Transactions by PDMRs
30th Jun 20263:00 pmRNSTotal Voting Rights
30th Jun 20269:18 amRNSHolding(s) in Company
22nd Jun 20263:13 pmRNSHolding(s) in Company
18th Jun 20261:04 pmRNSHolding(s) in Company
17th Jun 202610:08 amRNSPre Stabilisation Notice
15th Jun 20264:12 pmRNSHolding(s) in Company
15th Jun 20261:00 pmRNSFirst Interim Dividend for 2026 - Exchange Rate
11th Jun 20265:10 pmRNSNotice of redemption
2nd Jun 20262:41 pmRNSHolding(s) in Company
29th May 20264:01 pmRNSTotal Voting Rights
29th May 20264:00 pmRNSNotification of issuance under block listing
27th May 20264:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSIssuance of senior unsecured notes
21st May 20267:00 amRNSHSBC investor and analyst Asia seminar
20th May 20267:00 amRNSHSBC investor and analyst Asia seminar
18th May 20264:20 pmRNSIssuance of perpetual subordinated CC securities
15th May 202611:00 amRNSNotice of redemption and cancellation of listing
12th May 20264:40 pmRNSIssuance of senior unsecured notes (USD)
12th May 20264:05 pmRNSIssuance of senior unsecured notes
12th May 20267:00 amRNSIssuance of perpetual subordinated CCS
8th May 20262:15 pmRNSResult of AGM
8th May 202610:03 amRNSAGM Statements
7th May 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
6th May 202610:00 amRNSBoard and Committee Composition
5th May 202612:30 pmRNSPublication of base prospectus supplement
5th May 20267:00 amRNSEarnings Release 1Q26 Zoom Meeting
5th May 20267:00 amRNSEarnings Release 1Q26
1st May 20264:00 pmRNSDirector/PDMR Shareholding
30th Apr 20263:01 pmRNSTotal Voting Rights
30th Apr 20263:00 pmRNSNotification of issuance under block listing
28th Apr 20269:51 amRNSHolding(s) in Company
23rd Apr 202610:00 amRNSNotice of redemption & cancellation of listing
22nd Apr 202610:00 amRNSOverseas Regulatory Announcement - Board Meeting
20th Apr 202612:45 pmRNSFourth Interim Dividend for 2025 - Exchange Rate
17th Apr 20267:00 amRNSAmended and Restated Notice of Redemption
16th Apr 20262:30 pmRNSNotice of redemption
16th Apr 20269:02 amRNSHolding(s) in Company
14th Apr 202610:30 amRNSOverseas Regulatory Announcement - Grant of Awards
30th Mar 20265:01 pmRNSTotal Voting Rights
30th Mar 20265:00 pmRNSNotification of issuance under block listing
30th Mar 20264:40 pmRNSPublication of base prospectus
27th Mar 20261:30 pmRNSIssuance of senior unsecured notes
27th Mar 20269:00 amRNS2026 AGM - Documents available at NSM
26th Mar 20264:00 pmRNSDirector/PDMR Shareholding
25th Mar 20269:30 amRNSHong Kong Waiver-Contingent Convertible Securities
24th Mar 20264:30 pmRNSDirector/PDMR Shareholding
24th Mar 20263:50 pmRNSIssuance of contingent convertible securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.